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Background: We previously showed that use of portable non-invasive ventilation 20 
(pNIV) during recovery periods within intermittent exercise improved breathlessness 21 
and exercise tolerance in COPD patients compared to pursed-lip breathing (PLB). 22 
However, in a minority of patients recovery from dynamic hyperinflation (DH) was 23 
better with PLB, based on inspiratory capacity. We further explored this using 24 
Optoelectronic Plethysmography to assess total and compartmental 25 
thoracoabdominal volumes.  26 
Methods: Fourteen COPD patients (mean±SD) (FEV1: 55±22% predicted) underwent, 27 
in a balanced order sequence, two intermittent exercise protocols on the cycle 28 
ergometer consisting of five repeated 2-min exercise bouts at 80% peak capacity, 29 
separated by 2-min recovery periods, with application of pNIV or PLB in the first 30 
minute of recovery. 31 
Results: Our findings identified 7 patients showing recovery in DH with pNIV (DH 32 
responders) while 7 showed similar or better recovery in DH with PLB.  When pNIV 33 
was applied, DH responders compared to DH non-responders exhibited greater tidal 34 
volume (by 0.8±0.3 L, p=0.015), inspiratory flow rate (by 0.6±0.5 L/sec, p=0.049), 35 
prolonged expiratory time (by 0.6±0.5 sec, p=0.006) and duty cycle (by 0.7±0.6 sec, 36 
p=0.007). DH responders showed a reduction in end-expiratory thoracoabdominal 37 
DH (by 265±633 ml) predominantly driven by reduction in the abdominal 38 
compartment (by 210±494 ml); this effectively offset end-inspiratory rib-cage DH. 39 
Compared to DH non-responders, DH responders had significantly greater BMI by 40 
8.4±3.2 kg/m2, p=0.022 and tended towards less severe resting hyperinflation by 41 
0.3±0.3 L.  42 
Conclusion: COPD patients who mitigate end-expiratory rib-cage DH by expiratory 43 
abdominal muscle recruitment benefit from pNIV application. 44 
 45 
 46 
Keywords: Exercise, NIV, COPD, Opto-Electronic Plethysmography, Dynamic 47 
Hyperinflation 48 













New and Noteworthy 60 
Compared to the pursed-lip breathing technique, acute application of portable non-61 
invasive ventilation during recovery from intermittent exercise improved end-62 
expiratory thoracoabdominal dynamic hyperinflation (DH) in 50% of COPD patients 63 
(DH responders). DH responders, compared to DH non-responders, exhibited a 64 
reduction in end-expiratory thoracoabdominal DH predominantly driven by the 65 
abdominal compartment that effectively offset end-expiratory rib cage DH. The 66 
essential difference between DH responders and DH non-responders was, therefore, 67 




Expiratory flow limitation (EFL) is an important pathophysiological hallmark in 70 
Chronic Obstructive Pulmonary Disease (COPD), limiting exercise tolerance 71 
secondary to increased dynamic hyperinflation (DH) (13, 38). DH is manifested by 72 
increased end-expiratory lung volume that reduces inspiratory reserve volume (IRV). 73 
This forces COPD patients to breathe close to their total lung capacity (TLC), 74 
increasing both work of breathing and breathlessness (38). Additionally, DH may 75 
cause adverse central hemodynamic effects by reducing venous return, thus 76 
impairing the normal increase in stroke volume and cardiac output during exercise 77 
(1, 50). Non-invasive ventilation (NIV) is one of the ergogenic approaches that has 78 
been implemented to reduce DH and breathlessness, thus improving exercise 79 
tolerance in COPD (3). 80 
A limited number of studies have assessed the effect of NIV on the magnitude of DH 81 
during exercise by measuring inspiratory capacity (IC) (38) in patients with COPD 82 
with conflicting evidence. Accordingly, application of NIV during exercise has shown 83 
to either increase DH (43), or decrease DH (39), albeit the change in IC in the latter 84 
study (39) still indicated significant DH above resting values (38). IC manoeuvres are, 85 
however, effort dependent and therefore the estimate of DH may be inaccurate, 86 
especially during intense exercise. 87 
Application of a portable NIV (pNIV) device (VitaBreath, Philips Respironics 88 
Morrisville, PA, USA) was recently shown to increase intermittent exercise tolerance 89 
and improve breathlessness in comparison to the pursed lip breathing (PLB) 90 
technique in 16/24 COPD patients when applied in the first minute of recovery 91 
periods during successive bouts of intermittent exercise (10, 48). VitaBreath is a 92 
portable, handheld, battery-powered, pNIV device that provides an expiratory 93 
positive airway pressure (EPAP) of 8 cmH2O and inspiratory positive airway pressure 94 
(IPAP) of 18 cmH2O (17). The VitaBreath device is no longer commercially available, 95 
but similar devices may come to market. Nevertheless, the aforementioned studies 96 
(10, 48) provided proof of concept on how NIV can be applied intermittently during 97 
recovery from exercise in patients with COPD, and how to identify patients most 98 
likely to respond to NIV. Furthermore, considering that use of pNIV in activities of 99 
daily living improves anxiety around breathlessness, as well as perceived time of 100 
recovery from it (48), ventilatory support during recovery from exercise is potentially 101 
of value to the COPD patient.  102 
We previously showed that whilst the majority of COPD patients experienced a 103 
greater reduction in DH with pNIV compared to PLB (DH responders) based on 104 
measurement of IC, in 8/24 of patients the improvement in DH was greater with PLB 105 
than pNIV (DH non-responders); it may be that the fixed IPAP and EPAP were 106 
suboptimal, at least for DH non-responders (10, 48). Interestingly, DH non-107 
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responders tended to have greater resting airway obstruction and baseline lung 108 
hyperinflation, whilst during exercise they exhibited greater restrictions to tidal 109 
volume expansion compared to DH responders. Tidal volume expansion during 110 
exercise depends on the degree of exercise-induced EFL (12, 18, 33) and the ability 111 
to decrease end-expiratory thoracoabdominal volume by recruitment of expiratory 112 
abdominal muscles (12, 27, 49). Accordingly, it was suggested that DH responders 113 
would represent those patients exhibiting greater capacity to increase tidal volume 114 
by recruiting expiratory abdominal muscles (11).  However, in our earlier studies (10, 115 
48) we did not assess the degree of expiratory abdominal muscle recruitment. 116 
Furthermore, DH was assessed one minute following pNIV and PLB application by 117 
performing inspiratory IC manoeuvres (36). Thus, the acute effect of pNIV 118 
application on DH was not investigated.  119 
Optoelectronic Plethysmography (OEP) allows breath-by-breath assessment of end-120 
inspiratory and end-expiratory total and compartmental (rib cage and abdominal) 121 
thoracoabdominal volumes without the necessity to perform IC manoeuvres (2). The 122 
purpose of the present study was to assess total and compartmental 123 
thoracoabdominal volumes during acute application of pNIV during recovery from 124 
exercise. We hoped to better understand why the rate of recovery from DH is slower 125 
with pNIV compared to PLB in DH non-responders compared to DH responders (10, 126 
48).  127 
Earlier work has shown that application of continuous positive airway pressure 128 
(CPAP: 7.5-10 cm H2O) during exercise is associated with inflation of the rib cage 129 
compartment with concomitant deflation of the abdominal compartment, secondary 130 
to expiratory abdominal muscle recruitment, in the majority of COPD patients (43). 131 
Accordingly, it was reasoned that during acute application of pNIV in recovery from 132 
intermittent exercise, DH responders would exhibit greater recruitment of expiratory 133 
abdominal muscles alongside greater expiratory flow rates when compared to DH 134 
non-responders. 135 




Study design 138 
This was a crossover study investigating the acute effect of pNIV compared to the 139 
PLB technique on thoracoabdominal volumes in recovery from intermittent exercise. 140 
Central hemodynamic responses, local respiratory muscle oxygen availability and 141 
respiratory muscle electromyography activity were also assessed. Patients 142 
underwent two sub-maximal intermittent exercise tests sustained at 80% of peak 143 
work rate (WRpeak) on a cycle ergometer using both pNIV and the PLB technique 144 
during recovery from exercise in a balanced order on the same day. The 145 
investigations were carried out following the rules of the Declaration of Helsinki of 146 
1975 (51), revised in 2013. NHS Research Ethics Committee approval (Ref: 147 
19/NE/0091) and Clinical Trials registration (NCT03848819) were obtained. All 148 
participants provided written informed consent. 149 
Participants 150 
Inclusion criteria were stable COPD, aged 40 years or older with a smoking history of 151 
at least 10 pack years, and who exhibited substantial exercise-induced DH at the 152 
limit of incremental cycle exercise tolerance (i.e.: change in inspiratory capacity from 153 
baseline >0.15 L or >4.5% of predicted resting IC) (38). Exclusion criteria included 154 
COPD exacerbation within 6 weeks prior to exercise testing, unstable comorbidities 155 
and inability to exercise.  156 
Baseline Assessment – Visit 1 157 
Prior to exercise testing, participants attended North Tyneside General Hospital for 158 
baseline assessment. This included spirometry, body plethysmography lung volume 159 
measurements, diffusion capacity, resting electrocardiography (ECG) evaluation, 160 
medical history and examination. Following medical assessment, patients performed 161 
a ramp incremental exercise test with increments of 5-10 watts every minute to the 162 
limit of tolerance on a cycle ergometer (Ergoselect 200, Ergoline GmbH, Bitz, 163 
Germany) (48) to establish presence of DH (38, 48) and WRpeak. 164 
Intermittent Exercise Protocol – Visit 2 165 
Patients underwent two intermittent exercise protocols on the cycle ergometer 166 
(Ergoselect 200, Ergoline GmbH, Bitz, Germany). The exercise protocol consisted of 167 
five repeated 2-min exercise bouts at 80% of predefined WRpeak, separated by 2-168 
min recovery periods, to allow application of pNIV or the PLB technique. During the 169 
first minute of each recovery period, patients breathed through the pNIV device or 170 
adopted the PLB technique. During the second minute of each recovery period 171 
patients breathed normally. Before each exercise test patients underwent three-172 
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minutes of baseline measurements (quiet breathing-QB) followed by a three-minute 173 
warm-up period with no cycling load.  174 
After the termination of the 5th exercise bout patients underwent 5 minutes of 175 
measurements during recovery. Patients performed IC manoeuvres to allow 176 
calculation of thoracoabdominal volumes at total lung capacity (TLC) during QB, the 177 
second minute of each exercise bout and each recovery period as previously 178 
described (40). Total and compartmental thoracoabdominal volumes were recorded 179 
by OEP during QB, exercise and recovery periods. Circulatory responses and local 180 
respiratory muscle oxygenation were measured non-invasively using impedance 181 
cardiography technology and near-infrared spectroscopy, respectively throughout 182 
QB, exercise and recovery periods. Electromyography (EMG) activity of respiratory 183 
muscles (intercostal, scalene and rectus abdominis) was recorded during the first 184 
minute of each recovery period using surface electromyography electrodes. 185 
Peripheral oxygen saturation (SpO2%) was continuously monitored by a pulse 186 
oximeter (Onyx Vantage 9590, Nonin Medical Inc, USA). Finally, following each 187 
exercise bout dyspnoea and leg discomfort were recorded on the modified 1-10 Borg 188 
scale (6). 189 
pNIV and pursed lip breathing 190 
During the first minute of each recovery period in one of the exercise tests, pNIV was 191 
applied via the VitaBreath device. The VitaBreath is a portable, handheld, battery-192 
powered, non-invasive ventilation device (pNIV) intended to reduce activity-related 193 
shortness of breath (17). It delivers fixed high inspiratory (18 cm H2O) and expiratory 194 
(8 cm H2O) pressures, but it can only be used during recovery periods interspersing 195 
bouts of physical activity. 196 
Patients practiced using the VitaBreath device and the correct adoption of the PLB 197 
technique with guidance from a respiratory nurse during the first visit. During the 198 
second visit a respiratory physician was present to ensure that patients were able to 199 
follow the instructions provided by the researchers and perform the pNIV and PLB 200 
techniques correctly. 201 
Thoracoabdominal volumes 202 
During both intermittent exercise tests, thoracoabdominal wall kinematics were 203 
assessed by the OEP system (BTS, Milano, Italy) during QB, the second minute of 204 
each exercise bout and throughout the recovery periods as follows: the movement 205 
of 89 retro-reflective markers placed over the anterior, lateral and posterior chest 206 
wall was recorded. Each marker was tracked by eight video cameras (Smart System 207 
BTS, Milan, Italy), four in front of the subject and four behind. Subjects used grasp 208 
handles positioned at the mid sternum level to lift their arms away from the rib cage 209 
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so that lateral markers could be visualised. Dedicated software reconstructed the 210 
three-dimensional coordinates of the markers in real time by stereophotogrammetry 211 
and calculated total and compartmental thoracoabdominal volume and volume 212 
variations using Gauss’s theorem. The chest wall was modelled as being composed 213 
of two compartments—the rib cage and the abdominal compartments. Total 214 
thoracoabdominal volume is the sum of these two compartmental volumes (49). 215 
Circulatory responses 216 
During both intermittent exercise tests, participants were connected to a portable 217 
device using impedance cardiography technology (Physio Flow, Enduro, PF-07, 218 
Manatec Biomedical, Folschviller, France). The validity of cardiac output recordings 219 
using Physio Flow, in comparison to the dye dilution method and the direct Fick 220 
method, has been confirmed in both healthy subjects and those with 221 
cardiorespiratory disease (9, 26, 46). Cardiac output (CO), heart rate and stroke 222 
volume were recorded continuously as previously detailed (34). Six electrodes were 223 
placed on patients, two on the left carotid artery (Z1 and Z2), two in the breast area 224 
(EKG1 and EKG2) and two in the chest area [Z3 and Z4-EKG3 (neutral)] (34). 225 
Local respiratory muscle oxygen availability 226 
Local respiratory muscle oxygen availability of the intercostal muscles (7th intercostal 227 
space) and rectus abdominis was assessed throughout QB, exercise and recovery 228 
periods by a NIRO 200 spectro-photometer (Hamamatsu Photonics KK, Hamamatsu, 229 
Japan). The NIRO 200 uses Spatially Resolved Spectroscopy method to detect 230 
changes in Tissue Oxygenation Index (TOI), Oxygenated haemoglobin (HbO2), and 231 
Deoxygenated haemoglobin (HHb) and its validity has been previously established 232 
(29). Two sets of NIRS optodes were placed, one on the skin over the 7th left 233 
intercostal space at the midaxillary line and the other over the left rectus abdominis. 234 
The optode separation distance was 4 cm, corresponding to a penetration depth of 235 
approximately 2 cm. The left intercostal and rectus abdominis were used in order to 236 
avoid potential blood flow contributions from the liver (25). NIRS values were zeroed 237 
at the start point of each exercise protocol. NIRS data were sampled at 6 Hz and 238 
exported in document file format and averaged for offline analysis at 60 s intervals. 239 
 240 
Respiratory muscle electromyography 241 
EMG was used to assess respiratory muscle activation during application of pNIV or 242 
PLB. Prior to placement of electrodes, the skin was cleaned. Surface electrodes 243 
(Delsys Trigno, Delsys, Boston, MA, USA) were placed as previously been described 244 
(8) on the surface over the right seventh intercostal space, 2 cm lateral to the 245 
umbilicus, over the muscle mass of rectus abdominis and over the scalene muscle. 246 
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EMG data were recorded during quiet breathing and at the first minute of each 247 
recovery period when pNIV or PLB were applied for 30 seconds. Finally, EMG data 248 
were recorded at 2000Hz and were filtered at 25–500 Hz during each trial (Spike 2, 249 
Cambridge Electronic Design, Cambridge, UK) (8). All EMG was processed using 250 
custom written scripts in Matlab (The Mathworks, Inc. Natick, MA, USA). Data are 251 
presented as fractional change in electromyographic activity from baseline values. 252 
Statistical analysis 253 
Estimation of sample size within each breathing modality (i.e. pNIV and PLB) was 254 
based on the results of our previous study (48). Using the minimum clinically 255 
important difference in DH assessed by inspiratory capacity manoeuvres defined as 256 
4.5% of predicted resting IC (mean: 120 ml within our previous cohort) and observed 257 
SD: 110 ml (48), an alpha significance level of 0.05 (2-sided) and 80% power, a 258 
minimum total sample size of 13 patients was required. Fourteen patients were 259 
recruited in order to achieve balance in the order that the pNIV and PLB trials were 260 
performed. Seven patients had previously participated in a study undertaken by our 261 
group (48). Data are presented as mean ± standard deviation (SD) unless otherwise 262 
stated. DH responders were identified as patients showing a reduction in end-263 
expiratory thoracoabdominal volume with pNIV at least 120 ml greater than that 264 
seen with PLB at the first minute of recovery, whereas DH non-responders were 265 
those failing to show this degree of response with pNIV compared to PLB (10). The 266 
120 ml dichotomous value was based on our earlier study (10) indicating that 267 
patients showing an reduction in DH ≥ 120 ml (40) when using pNIV compared to the 268 
PLB technique were identified as DH responders. Patients showing a decrease in DH 269 
< 120 ml, or an increase,in DH using pNIV compared to PLB were defined as DH non-270 
responders. Independent sample t-tests were employed to compare baseline 271 
characteristics between DH responders and DH non-responders. Two-way repeated 272 
measures ANOVA followed by least significant difference (LSD) post-hoc analysis was 273 
employed to assess differences in total and compartmental thoracoabdominal 274 
volumes, breathing pattern, circulatory responses and local respiratory muscle 275 
oxygenation between both the pNIV device and PLB exercise tests, and between DH 276 
responders and DH-non responders. Activation of respiratory muscle EMG activity is 277 
presented as percentage of change from baseline (QB) and was analysed using 278 
paired sample t-tests. Data present mean values for thoracoabdominal and 279 
compartmental volumes, circulatory responses, local respiratory muscle oxygen 280 
availability, and respiratory muscle EMG activity for: QB, the 5 exercise bouts, the 1st 281 
and 2nd minutes of all 5 recovery periods as well as the 3rd, 4th and 5th minute of 282 
recovery following the final exercise bout. The level of significance for all analyses 283 
was set at p < 0.05. 284 




Overall, patients had moderately severe airway obstruction and significant lung 287 
hyperinflation at rest (Table 1). Peak exercise capacity was severely impaired; 288 
patients exhibited exercise-induced DH and low peak oxygen consumption at the 289 
limit of tolerance (Table 1). DH responders had significantly greater BMI and 290 
inspiratory flow rate at rest (Table 1). 291 
Thoracoabdominal volumes for all patients 292 
Across all 14 patients, total end-expiratory and end-inspiratory thoracoabdominal 293 
and compartmental volumes were not significantly different during exercise 294 
between PLB and pNIV trials (Figure 1). Compared to QB, end-expiratory 295 
thoracoabdominal volume increased by an average of 266±152 ml during exercise 296 
indicating presence of DH (38). Thoracoabdominal IRV at the end of exercise was on 297 
average 645±439 ml (Figure 1a). Compared to QB at the end of exercise we found an 298 
average increase of 326±291 ml (p=0.001) in thoracoabdominal volume at TLC 299 
(Figure 1a). 300 
With acute pNIV application in the first minute of recovery total end-inspiratory 301 
thoracoabdominal volume was greater compared to PLB application (by: 230±207 302 
ml; p=0.047) (Figure 1a), secondary to greater end-inspiratory rib cage volume (by: 303 
266±196; p=0.005) (Figure 1b). Total end-expiratory thoracoabdominal volumes 304 
were not different (p=0.673) between acute PLB and pNIV applications in the first 305 
minute of recovery (Figure 1a). During pNIV application there was a greater increase 306 
in end-expiratory rib cage volume (by 198±185 ml p=0.047 value) (Figure 1b) 307 
compared to PLB, which was partially compensated by the lower end-expiratory 308 
abdominal volume (by 141±124 ml p=0.022) (Figure 1c). IRV (relative to TLC at the 309 
end of exercise) was on average 257±227 (p=0.038) ml lower with acute pNIV 310 
application compared to PLB, indicating ventilatory constraints (36). At the 5th 311 
minute of recovery following the last exercise bout, neither end-inspiratory nor end-312 
expiratory total thoracoabdominal volumes returned to levels recorded during QB 313 
(Figure 1a). 314 
Thoracoabdominal volumes during exercise 315 
During exercise total end-expiratory thoracoabdominal volumes were not different 316 
(p>0.05) between pNIV and PLB trials for DH responders and DH non-responders, 317 
(Figure 2). DH responders and DH non-responders exhibited an increase in end-318 
expiratory thoracoabdominal volume (by: 281±135 ml and by: 248±161 ml, 319 
respectively) compared to QB, indicating exercise-induced DH (38) (Figure 2a & 2d). 320 
However, DH responders significantly decreased (p<0.05) end-expiratory abdominal 321 
volume during exercise compared to QB in both trials (Figure 2c), whereas DH non-322 
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responders maintained end-expiratory abdominal volume unchanged from QB in 323 
both trials (p>0.05) (Figure 2f). Exercise IRV was not different (p=0.391) between DH 324 
responders (644±513 ml) and DH non-responders (528±353 ml) (Figure 2a & 2d). 325 
During exercise DH responders exhibited greater inspiratory and expiratory flow 326 
rates compared to DH non-responders (Figure 3 a & 3b). 327 
DH responders in recovery from exercise 328 
Our analysis identified 7 patients as DH responders and 7 patients as DH non-329 
responders (Table 1). In DH responders, during acute application of pNIV compared 330 
to PLB, total end-expiratory thoracoabdominal volume was lower by 209±422 ml (38) 331 
(Figure 2a), secondary to significantly lower end-expiratory abdominal volume with 332 
pNIV compared to PLB (by: 219±197 ml; p=0.026) (Figure 2c), thereby indicating 333 
greater expiratory abdominal muscle recruitment. In DH responders during acute 334 
application of pNIV compared to PLB, numerical differences did not reach statistical 335 
significance for total end-inspiratory thoracoabdominal volume (by 224±465 ml; 336 
p=0.250) (Figure 2a) consequently to differences in end-inspiratory rib cage volume 337 
(by 186±368 ml; p=0.230) (Figure 2b). IRV with pNIV tended to be lower (p=0.078) 338 
compared to PLB (by 302±421 ml) (Figure 2a and Table 2). At the 5th minute of 339 
recovery following the last exercise bout, neither end-inspiratory nor end-expiratory 340 
total thoracoabdominal volumes returned to levels recorded during QB (Figure 2a). 341 
DH non-responders in recovery from exercise 342 
In DH non-responders, during acute application of pNIV compared to PLB, total end-343 
expiratory thoracoabdominal volume was greater (p=0.001) by 356±153 ml (Figure 344 
2d) secondary to greater end-expiratory rib cage volume with pNIV compared to PLB 345 
(by: 416±86; p=0.001) (Figure 2e) and unchanged end-expiratory abdominal volume 346 
(Figure 2f). During acute application of pNIV total end-inspiratory thoracoabdominal 347 
volume was greater compared to PLB (by: 238±218 ml; p=0.047) (Figure 2d), 348 
secondary to greater end-inspiratory rib cage volume (by: 346±199 ml; p=0.004) 349 
(Figure 2e). There was no significant difference in IRV between pNIV and PLB 350 
application (p=0.252) (Figure 2d and Table 2). At the 5th minute of recovery following 351 
the last exercise bout, neither end-inspiratory nor end-expiratory total 352 
thoracoabdominal volumes returned to levels recorded during QB (Figure 2d). 353 
Differences between DH responders and non-responders in recovery from exercise 354 
Considering pNIV application alone, DH responders compared to DH non-responders 355 
exhibited a reduction in end-expiratory thoracoabdominal DH (by 265±633 ml) 356 
predominantly driven by reduction in the abdominal compartment (210±494 ml), 357 




Breathing pattern in DH responders and DH non-responders 360 
DH responders: During acute pNIV application compared to PLB, DH responders had 361 
greater minute ventilation (by: 6.5±6.4 L/min; p= 0.009), secondary to greater tidal 362 
volume (by: 0.5±0.4 L; p=0.002) without any differences in breathing frequency, 363 
inspiratory and expiratory time, or duty cycle (Table 2). During acute pNIV 364 
application compared to PLB, DH responders exhibited greater inspiratory flow rate 365 
(by: 0.4±0.3 L/sec; p=0.001) and greater expiratory flow rate (by: 0.2±0.2 L/sec; 366 
p=0.048) (Figures 3a & 3b, Table 2). There were no differences either in average 367 
values for breathlessness (p=0.745) or in leg discomfort (p=0.880) between pNIV and 368 
PLB application in DH responders (Table 2).  369 
DH non-responders: Compared to PLB, with acute pNIV application DH non-370 
responders increased their minute ventilation (by: 5.7±4.5 L/min; p=0.018) by 371 
adopting a more tachypnoeic breathing pattern (compared to DH responders) as 372 
breathing frequency was greater with pNIV compared to PLB (by: 7±6 breaths/min; 373 
p=0.002) (Table 2). The tachypnoeic breathing pattern resulted in lower inspiratory 374 
time (by: 0.3±0.2 sec; p=0.019), lower expiratory time (by: 0.8±0.6 sec; p=0.001) and 375 
lower total duty cycle (by: 1.1±0.8 sec; p=0.001) with pNIV application compared to 376 
PLB (Table 2). Moreover, with pNIV application compared to PLB there was a trend 377 
for greater inspiratory flow rate (by 0.2±0.2 L/sec p=0.064), whilst expiratory flow 378 
rate was significantly greater (by: 0.2±0.2 L/sec; p=0.011) (Figures 3a & 3b, Table 2). 379 
Following acute application of pNIV compared to PLB breathlessness was lower in DH 380 
non-responders (by: 1.1±0.9; p=0.001), whilst leg discomfort was unaffected 381 
(p=0.203) (Table 2).  382 
Differences in breathing pattern between DH responders and DH non-responders 383 
When pNIV was applied, DH responders compared to DH non-responders exhibited 384 
greater tidal volume (by 0.8±0.5 L, p=0.015), inspiratory flow rate (by 0.6±0.5 L/sec, 385 
p=0.049), prolonged expiratory time (by 0.6±0.5 sec, p=0.006) and duty cycle (by 386 
0.7±0.6 sec, p=0.007) whilst breathing frequency was lower (p=0.019) (Table 2).  387 
With pNIV application numerical differences for expiratory flow rate in DH 388 
responders compared to DH non-responders (by 0.2±0.5 L/min) did not reach 389 
statistical significance (p=0.389). IRV relative to end-exercise TLC during acute pNIV 390 
application was not different between DH responders and DH non-responders 391 
(p=0.968) (Figures 2a and 2d).  392 
Central haemodynamic responses 393 
CO was unaffected by acute pNIV application compared to PLB in both DH 394 
responders and DH non-responders (Figure 4c & 4f). However, in DH responders, 395 
throughout recovery from exercise, pNIV application resulted in significantly greater 396 
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CO compared to PLB (p=0.024) (Figure 4c) and did not return towards baseline at the 397 
5th minute of recovery. In DH non-responders there were no differences in the 398 
pattern of response in any of the central haemodynamic variables between pNIV and 399 
PLB application in recovery from exercise (Figure 4 d-f), whereas CO returned 400 
towards baseline at the 5th minute of recovery. 401 
EMG muscle activity 402 
Surface muscle EMG revealed two different patterns of respiratory muscle activation 403 
during recovery from exercise. DH responders exhibited greater inspiratory and 404 
expiratory EMG muscle activity (delta of percentages from baseline between 405 
conditions) with pNIV application compared to PLB as this was reflected by the 406 
greater activation of intercostal (by: 20±16%; p=0.043), scalene (by: 50±33%; 407 
p=0.013) and rectus abdominis (by: 67±57%; p=0.014) muscles (Table 3). In contrast, 408 
DH non-responders using pNIV compared to PLB exhibited reduced inspiratory 409 
(intercostal and scalene) EMG muscle activity, and increased expiratory (abdominal) 410 
EMG muscle activity. This was reflected by lower EMG activity of intercostal (by: 411 
32±22%; p=0.009) and scalene (by: 32±30%; p=0.047) muscles and greater EMG 412 
activity of rectus abdominis muscle (by: 33±31%; p=0.049) (Table 3). Accordingly, 413 
greater EMG activity of the inspiratory muscles during pNIV compared to PLB was 414 
evident in DH responders compared to DH non-responders for intercostal (p=0.004) 415 
and scalene (p=0.007) muscles. There was no difference in the pattern of rectus 416 
abdominis EMG muscle activity between DH responders and DH non-responders 417 
with pNIV compared to PLB applications (p=0.538); both DH responders and DH non-418 
responders increased EMG abdominal muscle activity with pNIV compared to PLB 419 
(Table 3). However, DH responders exhibited a two fold greater increase in EMG 420 
abdominal muscle activity with pNIV compared to PLB in comparison to DH non-421 
responders (Table 3). 422 
Respiratory muscle oxygen availability 423 
In DH responders, when pNIV was applied compared to PLB, deoxygenated 424 
haemoglobin was greater in intercostal muscles (by: 2.3±2.1 µmol/L; p=0.048) and 425 
rectus abdominis muscle (by: 1.8±1.7 µmol/L; p=0.047). In DH non-responders, pNIV 426 
application compared to PLB caused greater levels of deoxygenated haemoglobin in 427 
intercostal (by: 2.1±1.5 µmol/L; p=0.040) and rectus abdominis (by: 4.6±4.0 µmol/L; 428 
p=0.045) muscles. There were no differences in the pattern and magnitude of 429 
response of deoxygenated haemoglobin of intercostal and abdominal muscles 430 




Main findings 433 
In line with our earlier studies (10, 48) we have identified two different patterns of 434 
DH response to acute application of pNIV compared to PLB in recovery from exercise 435 
in COPD: DH responders showing a greater improvement in DH using pNIV compared 436 
to PLB of at least 120 ml and DH non-responders failing to show this degree of 437 
response with pNIV compared to PLB. When pNIV was applied in recovery from 438 
exercise, DH responders compared to DH non-responders exhibited greater tidal 439 
volume, inspiratory and expiratory flow rates, prolonged expiratory time and duty 440 
cycle, and experienced lower end-expiratory DH secondary to greater expiratory 441 
abdominal muscle recruitment. DH responders had significantly greater BMI and 442 
resting inspiratory flow rate, and less severe resting hyperinflation compared to DH 443 
non-responders. 444 
Study novelties 445 
To the best of our knowledge this is the first study to assess total and 446 
compartmental thoracoabdominal volumes acutely during application of a NIV 447 
method in recovery from exercise in patients with COPD. Use of optoelectronic 448 
plethysmography allowed patients to breathe normally and carry out ventilatory 449 
measurements without the need of a valve and mouthpiece. In contrast to our 450 
previous studies (10, 48), the present study used optoelectronic plethysmography to 451 
assess the magnitude of dynamic hyperinflation in recovery from exercise when 452 
using pNIV or PLB without requirement of inspiratory capacity manoeuvres that are 453 
effort dependent (1, 2). Finally, use of optoelectronic plethysmography allowed us to 454 
evaluate the breathing pattern throughout the application of pNIV and PLB including 455 
breath-by-breath recordings of expiratory and inspiratory time and flow rates, total 456 
duty cycle, tidal volume, breathing frequency, and minute ventilation. 457 
Differences in baseline characteristics between DH responders and non-responders 458 
One significant difference between DH responders and DH non-responders was 459 
elevated BMI presented in the group of DH responders. A recent study (10) argued 460 
that a possible mechanism that allowed DH responders compared to DH non-461 
responders to benefit from pNIV was the increased BMI (10). It has previously been 462 
reported that the respiratory muscles of COPD with high BMI might have a 463 
mechanical advantage in comparison to patients with normal BMI (35). This has been 464 
attributed to the increased inspiratory capacity (i.e. lower resting hyperinflation) in 465 
patients with high BMI, which was evident in the DH responders in the present 466 
study. Moreover, patients with high BMI might have an advantage when using pNIV, 467 
which applies a high expiratory positive airway pressure (8 cmH2O) in comparison to 468 
other NIV devices (7, 19, 22, 44, 45, 47). It is known that intrinsic positive end-469 
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expiratory pressure (PEEPi) needs to be closely matched with extrinsic positive end-470 
expiratory pressure (PEEPe) (31). If PEEPe is significantly lower than PEEPi there will 471 
be no improvement in operational lung volumes (14, 32). In contrast, if PEEPe is 472 
much greater than PEEPi, dynamic hyperinflation will worsen and result in adverse 473 
central haemodynamic responses (16, 28). Patients with higher BMI exhibit greater 474 
PEEPi (35), thus NIV devices with higher expiratory positive airway pressure (PEEPe), 475 
such as the VitaBreath device in the present study (8 cm H2O), might be better suited 476 
to patients with high BMI (10). Future devices may be able to tailor the expiratory 477 
pressure to overcome expiratory flow limitation in individual patients. 478 
DH responders 479 
Application of pNIV compared to PLB was associated with increased end-inspiratory 480 
rib cage and total thoracoabdominal volumes in DH responders. This finding is 481 
explained by the high fixed IPAP (18 cmH2O) provided by the VitaBreath device, but 482 
is in line with other NIV methods showing an inflation of the rib cage compartment 483 
with NIV application (43). However, application of pNIV compared to PLB lessened 484 
end-expiratory abdominal and total thoracoabdominal volumes in DH responders.  485 
It is well known that COPD patients develop varying degrees of expiratory flow 486 
limitation. This leads to DH at different ventilatory levels during exercise, but which 487 
greatly differ among patients with COPD (21, 49). Indeed, Vogiatzis and colleagues 488 
identified two different DH patterns during exercise and in recovery from exercise, 489 
namely early and late DH (49). COPD patients who developed late DH during exercise 490 
were those who compensated end-expiratory rib cage DH by expiratory abdominal 491 
muscle recruitment (49). When using pNIV, DH responders in the present study 492 
exhibited a similar pattern to that previously described for late DH (49); they were 493 
able to compensate end-expiratory rib cage DH by recruiting their expiratory 494 
abdominal muscles. Furthermore, during exercise and during acute pNIV application, 495 
DH responders exhibited greater expiratory flow rates compared to PLB thereby 496 
indicating lower degrees of expiratory flow limitation. Presumably, when using pNIV 497 
compared to PLB, expiratory abdominal muscle recruitment in conjunction with 498 
greater expiratory flow rate and marginally prolonged expiratory time was effective 499 
in reducing end-expiratory DH in recovery from exercise (27). Greater expiratory 500 
abdominal muscle recruitment with pNIV compared to PLB was in turn corroborated 501 
by greater rectus abdominis muscle EMG activity alongside increased rectus 502 
abdominis deoxygenated haemoglobin; this suggests greater oxygen extraction due 503 
to increased muscle activation. 504 
DH responders were less flow limited during exercise and during acute pNIV 505 
application compared to DH non-responders, inferred by the greater inspiratory and 506 
expiratory flow rates (Figure 3), allowing them to increase tidal volume more than 507 
DH non-responders. Thoracoabdominal tidal volume during acute application of 508 
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pNIV was nearly two-fold greater in DH responders than DH non-responders (Table 509 
2). DH responders were able to expand their tidal volume firstly by increasing their 510 
end-inspiratory thoracoabdominal volume, and secondly by decreasing their end-511 
expiratory thoracoabdominal volume during acute application of pNIV. This increase 512 
in tidal volume was the result of greater thoracoabdominal volume at total lung 513 
capacity, allowing a larger increase in end-inspiratory volume up to the point of 514 
reaching critical mechanical constraints (Figure 2 a) (38). Greater end-inspiratory 515 
thoracoabdominal volume was also associated with greater intercostal and scalene 516 
EMG muscle activity and inspiratory flow rates. The increased tidal volume during 517 
acute pNIV application was the result of increased abdominal muscle recruitment, 518 
which was greater in DH responders compared to DH non-responders (Figure 2c & 519 
2f). This finding is further supported by the EMG data on rectus abdominis showing a 520 
two-fold increase in EMG activity with pNIV compared to PLB in DH responders 521 
versus DH non-responders. Thus, greater expiratory abdominal power output (the 522 
product of their velocity of shortening and the force they develop) in DH responders 523 
was expressed more as expiratory flow and less as pressure secondary to lower 524 
dynamic airway compression (27). This is most likely the reason why we did not find 525 
impaired central hemodynamic responses with pNIV compared to PLB in DH 526 
responders. However, greater EMG rectus abdominis muscle activity with pNIV 527 
compared to PLB application may account for the lack of difference in dyspnoea 528 
levels despite lower DH, given that increased expiratory muscle activity during 529 
positive-pressure breathing has been postulated to increase breathlessness (42). 530 
Moreover, in DH-responders there was no meaningful difference in dyspnoea 531 
between pNIV and PLB. This might be attributed to IRV with pNIV been lower 532 
compared to PLB as a result of significantly greater tidal volume expansion with pNIV 533 
application (Table 2) (40).  Furthermore inspiratory muscle (intercostal and scalene) 534 
activity was significantly greater with pNIV compared to the PLB technique (Table 3). 535 
Increased inspiratory muscle effort has been shown to be associated with a rise in 536 
perceived inspiratory difficulty reflecting increased dissociation between the 537 
increased central neural drive and the blunted mechanical response of the 538 
respiratory system (23, 37). 539 
 540 
DH non-responders 541 
Application of pNIV compared to PLB was associated with increased end-inspiratory 542 
and end-expiratory rib cage volumes. However, the increase in end-expiratory rib 543 
cage volume was not compensated by a reduction in end-expiratory abdominal 544 
volume as reported above for DH responders. This led to an increase in total end-545 
expiratory thoracoabdominal volume and thus DH, which limited tidal volume 546 
expansion. In line with our earlier studies (10, 48) tidal volume expansion was 547 
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restricted with pNIV compared to PLB application; patients adopted a more 548 
tachypnoeic-breathing pattern that reduced inspiratory and expiratory time as well 549 
as duty cycle. However, both inspiratory and expiratory flow rates were greater with 550 
pNIV compared to PLB secondary to the high fixed airway pressures delivered pNIV. 551 
During pNIV compared to PLB, DH non-responders exhibited greater rectus 552 
abdominis EMG activity (and deoxygenated haemoglobin) which, despite the 553 
increase in expiratory flow rate, was not successful in mitigating end-expiratory 554 
thoracoabdominal DH. This is most likely occurred because in DH non-responders 555 
PEEPe did not closely match PEEPi (14), confirming earlier concerns that the fixed 556 
IPAP and EPAP were probably suboptimal, at least for DH non-responders (10, 48). 557 
DH non-responders may have benefited if the expiratory pressure was automatically 558 
tailored to the individual to overcome expiratory flow limitation, whilst avoiding 559 
excessive pressures.  560 
Furthermore, inspiratory EMG muscle activity was lower with pNIV compared to PLB 561 
as the high inspiratory positive airway pressure (18 cmH20) was effective in 562 
overcoming inspiratory flow limitation, thereby necessitating less effort from the 563 
inspiratory muscles. Reduced work of breathing with inspiratory positive airway 564 
pressure is possibly associated with lower dyspnoea (20). Interestingly, in DH non-565 
responders, dyspnoea was significantly lower in the pNIV trial compared to PLB. This 566 
is attributed to the finding that inspiratory muscle (intercostal and scalene) activity 567 
was significantly greater with PLB compared to the pNIV (Table 3), thereby inducing 568 
a greater rise in perceived inspiratory difficulty (23, 37). 569 
Thoracoabdominal volumes during exercise and in recovery 570 
In the present study, thoracoabdominal volume at total lung capacity increased from 571 
baseline during exercise by an average of 326 ml. This finding is in agreement with a 572 
previous study in which COPD patients progressively increased thoracoabdominal 573 
volumes at total lung capacity by approximately 200 ml, during a ramp incremental 574 
exercise protocol (49). However, despite the fact that patients in the present study 575 
performed intermittent submaximal exercise, we report greater increase in 576 
thoracoabdominal volumes at total lung capacity compared to that study (49). This 577 
might be attributed to the application of pNIV during the recovery periods between 578 
exercise bouts, which increased end-inspiratory thoracoabdominal volume in both 579 
DH responders and DH non-responders. Importantly, in both DH responders and DH 580 
non-responders end-expiratory thoracoabdominal volume did not recover towards 581 
quiet breathing by five minutes into recovery. This is in keeping with the studies (41, 582 
49) that found that dynamic hyperinflation 3-5 minutes into recovery from symptom 583 
limited exercise was greater than at baseline. The present study extends these 584 
findings by showing that in both DH responders and DH non-responders, rib cage 585 
hyperinflation during exercise and recovery should have enhanced the threshold 586 
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loading of the muscles of the rib cage compartment so that recovery of 587 
hyperinflation would take longer to return to baseline (41). 588 
Haemodynamic responses  589 
Previous studies have reported that application of NIV in patients with COPD at rest 590 
reduces cardiac output (4, 11). Our short application time of pNIV (1-min) in both DH 591 
responders and DH non responders may have prevented adverse circulatory effects; 592 
this is in contrast to the existing literature where NIV application exceeded 5 minutes 593 
and resulted in adverse circulatory responses (4, 5, 11, 24). 594 
Study limitations 595 
Some outcomes were clinically, but not statistically, significant. This may simply 596 
reflect the limited sample size and a definitive outcome may have been achieved in a 597 
larger population. The present study was powered to identify differences in the rate 598 
of DH between pNIV and PLB. Moreover, we did not measure PEEPi and work of 599 
breathing. Measurement of PEEPi could have helped us compare the differences 600 
between PEEPe provided by pNIV and the actual PEEPi of DH responders and DH 601 
non-responders; this in turn could have potentially further supported the 602 
interpretation of our findings. Assessment of the work of breathing would have 603 
allowed us compare our findings with the study by Petrof and colleagues (43) who 604 
employed CPAP during exercise and further corroborate their findings as we 605 
measured respiratory electromyography muscle activity. Although we only recorded 606 
the EMG activation of the respiratory muscles during the recovery periods, it is 607 
possible that signal could be contaminated by abdominal muscle activation for the 608 
purposes of core stabilization whilst sitting on the cycle ergometer. The validity of 609 
both surface EMG and NIRS recordings has been previously established (15, 29, 30). 610 
Although we ensured that the quality of our measurements was sufficient to include 611 
in our analysis, high adipose tissue on the abdomen is possible to have affected the 612 
quality of the EMG and NIRS signals.  613 
Furthermore, it is surprising that DH responders showed no difference in 614 
breathlessness between pNIV and PLB application. This finding might be due to the 615 
fixed duration of exercise as in our earlier study DH responders exercised for longer 616 
compared to DH non-responders consequently to lower breathlessness at isotime 617 
(10). Interestingly this earlier study from our group showed that in DH responders, 618 
use of pNIV during daily activities over a 12-week period made them less anxious 619 
about becoming breathlessness compared to DH non-responders (10).  620 
Finally, in contrast to the existing literature using other NIV methods (39, 43) 621 
inspiratory and expiratory positive airway pressures were fixed and could not be 622 
adjusted for each patient in the present study. Accordingly, DH non-responders may 623 
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have responded well to different settings tailored to their physiological needs. 624 
Individualized pressure titration using a NIV module with adjustable settings may 625 
have provided more useful insight by clarifying whether an optimal pressure setting 626 
exists that offers equivalent or superior relief compared to PLB. This technology 627 
already exists, has been incorporated in standard home ventilators and could be 628 
implemented in future pNIV devices. This warranties further studies to test this 629 
possibility. We did not assess the reproducibility of physiological measures during 630 
the pNIV and PLB trials to avoid exposure of patients to additional exercise testing. 631 
Clinical implications 632 
The delayed recovery of dynamic hyperinflation following cessation of intermittent 633 
exercise has important clinical implications when designing rehabilitative exercise 634 
training regimes for patients with severe COPD, particularly if NIV is to be applied 635 
only during recovery from exercise. It is apparent from our results that whilst acute 636 
pNIV application was effective only in a specific subgroup of patients, clinical 637 
characteristics such as baseline hyperinflation can help predict response. 638 
Furthermore, COPD patients whose breathing control resembles that of a healthy 639 
individual in recruiting expiratory muscles during exercise (1, 50) are more likely to 640 
benefit from NIV; they may mitigate rib cage dynamic hyperinflation by expiratory 641 
abdominal muscle recruitment. Nevertheless, DH non-responders were less 642 
breathless and had greater expiratory flow with pNIV, therefore pNIV was not 643 
without some benefit even to this subgroup of patients. During recovery from 644 
exercise the improvement in DH lasted only transiently (1-min, during pNIV 645 
application) in DH responders. If implementing the use of NIV in the pulmonary 646 
rehabilitation setting NIV should perhaps be applied for longer to facilitate complete 647 
recovery of DH before moving to a new exercise task. However, considering the 648 
variation in response we have reported, it is important that clinicians assess the 649 
response to pNIV on an individual basis in order to verify whether using a portable 650 
NIV device during rehabilitation or at home makes the patient feeling better or 651 
worse. An earlier study from our group showed that in DH responders, use of pNIV 652 
during daily activities over a 12-week period made them less anxious about 653 
becoming breathlessness compared to DH non-responders (10). 654 
 655 
Conclusions  656 
COPD patients most likely to benefit from NIV in their recovery from exercise are 657 
those who are able, during exercise and in recovery from exercise, to mitigate end-658 
expiratory rib cage dynamic hyperinflation by expiratory abdominal muscle 659 
recruitment alongside increased expiratory flow rates. 660 
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Figures legends 821 
 822 
Figure 1. Effect of the application of portable non-invasive ventilation (pNIV) (closed 823 
symbols) compared to pursed lip breathing (PLB) (open symbols) on: a) total 824 
thoracoabdominal volume, b) rib cage volume and c) abdominal volume in all patients. 825 
Circles: end-expiratory volume, triangles: end-inspiratory volume, rhombuses: total 826 
thoracoabdominal volume. Grey area highlights acute application of pNIV or PLB. Data are 827 
presented as mean ± SEM. QB: quiet breathing, REC: recovery. * p < 0.05 pNIV vs PLB. 828 
 829 
Figure 2. Effect of the application of portable non-invasive ventilation (pNIV) (closed 830 
symbols) compared to pursed lip breathing (PLB) (open symbols) in DH responders (left 831 
panel) and DH non-responders (right panel) on: a & d) total thoracoabdominal volume, b & 832 
e) rib cage volume and c & f) abdominal volume. Circles: end-expiratory volume, triangles: 833 
end-inspiratory volume, rhombuses: total thoracoabdominal volume. Grey area highlights 834 
acute application of pNIV or PLB. Data are presented as mean ± SEM. QB: quiet breathing, 835 
REC: recovery. * p<0.05 pNIV vs PLB, † p<0.05 QB vs exercise in end-expiratory volume, §; 836 
minimum clinical importance difference between pNIV and PLB. 837 
 838 
Figure 3. Effect of the application of portable non-invasive ventilation (pNIV) (closed 839 
symbols) compared to pursed lip breathing (PLB) (open symbols) in DH responders (circles) 840 
and DH non-responders (triangles) on: a) inspiratory flow rate and b) expiratory flow rate. 841 
Data are presented as mean ± SEM. QB: quiet breathing, REC: recovery.* p<0.05 pNIV vs 842 
PLB, ‡ p<0.05 between responders versus non-responders with pNIV. 843 
 844 
Figure 4. Effect of the application of portable non-invasive ventilation (pNIV) (closed 845 
symbols) compared to pursed lip breathing (PLB) (open symbols) in DH responders (left 846 
panel) and DH non-responders (right panel) on: a & d) stroke volume, b & e) heart rate and c 847 
& f) cardiac output. Data are presented as mean ± SEM. QB: quiet breathing, REC: recovery. 848 

















































































































































































































































































































































Age (years) 68.4±8.4  67.7±6.1 69.1±10.7 0.764 
BMI (kg/m2) 28.6±7.2  32.8±6.7 24.4±5.0 0.022 
FEV1 (L) 1.34±0.69  1.53±0.81 1.14±0.53 0.301 
FEV1 (% predicted) 55±22  56±23 54±21 0.861 
FVC (L) 2.91±1.07  3.28±1.00 2.53±1.08 0.204 
FVC (% predicted) 95±26  93±22 96±31 0.876 
FEV1/FVC 45±13  45±14 45±12 0.984 
TLC (% predicted)  126±36  134±41  117±30  0.432 
FRC (% predicted) 151±56  167±62 135±50 0.355 
RV (% predicted) 173±81  191±93 155±71 0.465 
IC (% predicted) 63±18  68±20 58±16 0.319 
IC/TLC (%) 35±10  34±8 37±13 0.581 
RV/TLC (%) 53±14  53±14 53±15 0.984 
DLco 
(% predicted) 
50±19  50±24 49±15 0.930 
Inspiratory flow 
rate (L/sec) 
0.5±0.2  0.6±0.2  0.4±0.1  0.042 
Expiratory flow 
rate (L/sec) 
0.3±0.1  0.3±0.2  0.3±0.1  0.266 
WRpeak (Watts)  56±27  63±31  49±21  0.097 
WRpeak 
(% predicted) 
54±30  52±39 56±22 0.778 
VO2peak           
(% predicted) 
71±19  72±19 69±20 0.758 
ΔIC peak (ml)  ‐575±246  ‐621±173  ‐529±309  0.501 
BMI,  body mass  index;  FEV1,  forced  expiratory  volume  in  the  first  second;  FVC, 






Table 2. Breathing pattern and symptoms during acute application of pNIV and PLB  
Responders Non-Responders 
 pNIV PLB p pNIV PLB p 
VT (L) 1.9±0.7 1.4±0.5 0.002 1.1±0.3* 1.2±0.4 0.369 
bf (breaths/min) 21±3 22±5 0.478 27±5* 20±4 0.002 
VE (L/min) 39.0±16.6 32.5±12.4 0.009 29.1±7.6 23.4±9.2 0.018 
Ti (sec) 1.1±0.2 1.2±0.3 0.454 1.0±0.2 1.3±0.3 0.019 
Te (sec) 1.9±0.4 1.8±0.3 0.765 1.3±0.3* 2.1±0.6 0.001 
Ttot (sec) 3.0±0.4 3.0±0.5 0.828 2.3±0.4* 3.4±0.8 0.001 
Inspiratory flow rate 
(L/sec) 1.8±0.6 1.4±0.5 0.001 1.2±0.4* 1.0±0.4 0.064 
Expiratory flow rate 
(L/sec) 1.1±0.5 0.9±0.4 0.048 0.9±0.2 0.7±0.3 0.011 
IRV (ml) 200±446 502±477 0.078 240±549 444±246 0.252 
Dyspnoea (Borg) 3.1±1.3 3.0±1.3 0.745 2.5±0.7 3.6±1.1 0.001 
Leg Discomfort 
(Borg) 3.8±1.7 3.9±2.0 0.880 3.5±0.9 4.0±1.5 0.203 
pNIV: portable non-invasive ventilation, PLB: pursed lip breathing, VT: tidal volume, bf: 
breathing frequency, VE: minute ventilation, Ti: inspiratory time; Te: expiratory time; 
Ttot: duty cycle time, IRV: inspiratory reserve volume *; p<0.05 responders versus non-





   pNIV  PLB  p  pNIV  PLB  p 
Intercostal 
(% baseline) 
111±26  91±28  0.043  103±33  135±70  0.009 
Scalene 
(% baseline) 
192±81  142±38 0.013  143±43  175±79  0.047 
Rectus abdominis 
(% baseline) 




Table 4. Respiratory muscle oxygen availability 
 Responders Non-Responders 
 pNIV PLB p pNIV PLB p 
ΔHbO2 intercostal 
(µmol/L) -2.0±4.2 -3.4±3.0 0.120 -1.7±1.6 -2.4±2.1 0.449 
ΔHbO2 abdominal 
(µmol/L) 0.8±1.0 -0.2±1.5 0.421 0.8±6.2 -3.3±3.9 0.378 
ΔHHb intercostal 
(µmol/L) 
3.5±3.0 1.2±1.4 0.048 5.3±3.7 3.2±4.7 0.040 
ΔHHb abdominal 
(µmol/L) 
4.6±1.7 2.8±3.8 0.047 3.5±3.3 -1.1±1.8 0.045 
ΔTOI intercostal 
(%) -3.0±1.9 -4.0±2.2 0.597 -3.4±1.1 -2.6±1.9 0.505 
ΔTOI abdominal 
(%) -4.1±3.2 -3.0±2.7 0.070 -5.8±2.6 -1.6±2.7 0.031 
pNIV; portable non-invasive ventilation, PLB; pursed lip breathing, ΔHbO2: change 
in oxygenated haemoglobin from baseline, ΔHHb: change in deoxygenated 
haemoglobin from baseline, ΔTOI: change in tissue oxygen index from baseline. 
Data are presented as mean ± SD 
 
